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Chemotherapy: 
Cyclophosphamide (CPA)
 FDA approved in 1959
 Treats breast, ovarian, blood, lung, lymph, nerves, eye, 
bone marrow and skin cancers
 Neuro- and retinoblastoma most common in kids
 Also treats autoimmune disorders like lupus
 Administered via injection or orally 
 Length of treatment varies based on response, dose and 
stage of disease, e.g. weeks in cancer patients to years for 
those suffering from lupus
http://www.sheknows.com/sheknows-cares/articles/806066/emotional-support-for-breast-cancer-patients-and-survivors-fosters-
hope; http://www.ellasteaparty.com/Resources.html
(CEZ)
Bioactivation of CPA:
5-Year Cancer Survival Rates 
Have Increased
 All cancers: 
 68% compared to 50% in 1977
 Breast cancer: 
 90% compared to 63% in the 1960s
 Childhood cancer: 
 80% compared to less than 50% before the 1970s
American Cancer Society, 2010
Obesity Contributing to Cancer
 34.9% of adults in America are obese
 40% of cancer cases are due to obesity
Center for Disease Control, 2014
http://www.cdc.gov/obesity/data/adult.html http://www.cancer.gov/cancertopics/factsheet/Risk/obesity
Hypothesis
PM exposure results in CEZ 
production and that lung tissue is 
being exposed to CEZ, which 
would activate a cellular 
protective response
Study Design
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Treatments:
LNCT = Lean control (DMSO:saline)
LNPM = Lean PM
OBCT = Obese control (DMSO:saline)
OBPM = Obese PM
14wks
Jackson Laboratories
No apparent impact of CEZ on 
lung morphology
Lean Control Obese Control
Investigation of altered drug 
metabolism gene expression
RNA isolation
Convert to cDNA Amplify the DNA
Genes investigated
 Microsomal epoxide hydrolase (mEH)
 Action can increase or decrease toxicity of a drug
 Super Oxide Dismutase 1 (SOD1)
 Detoxifies reactive oxygen species (free radicals)
 SOD2 was investigated but did not amplify 
 Glutathione S-Transferase isoforms mu & pi (GSTmu & GSTpi)
 Add glutathione to compounds for detoxification
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Obesity increases 
Causes increase in drug 
metabolism genes 
Aides in 
excretion
Hydrolysis 
allows for 
activation or 
excretion
mEH is increased by 
obesity and PM exposure 
Obesity or PM do not impact lung 
Sod1 expression
Lung Gstmu is unaffected by 
obesity or PM exposure
Lung Gstpi is not impacted by 
obesity or PM
Result Summary
 mEH:
 Obesity increased mRNA level, with additional 
increase in PM-treated obese mice
 SOD1, GSTmu and GSTpi:
 No significant results, too much variation
 Numerically obese control is higher than lean 
control suggesting potential effect of obesity  on 
lung gene expression
Conclusions
 Lung metabolism activation suggests chemical 
exposure, likely CEZ
 Obesity impacts metabolism gene expression in 
the mouse lung
 Lung response to PM was accelerated with obesity
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